Krystexxa Interactions
There are 30 drugs known to interact with Krystexxa (pegloticase), along with 2 disease interactions. Of the total drug interactions, 5 are major, and25 are moderate.
- View Krystexxa disease interactions (2)
Medications known to interact with Krystexxa
Note: Showing generic names only.
- allopurinol
- antihemophilic factor
- calaspargase pegol
- certolizumab
- coagulation factor ix
- doxorubicin liposomal
- eflapegrastim
- elapegademase
- epoetin beta-methoxy polyethylene glycol
- febuxostat
- irinotecan liposomal
- lesinurad
- lonapegsomatropin
- naloxegol
- pegademase bovine
- pegaptanib ophthalmic
- pegaspargase
- pegcetacoplan
- pegcetacoplan ophthalmic
- pegfilgrastim
- peginesatide
- peginterferon alfa-2a
- peginterferon alfa-2b
- peginterferon beta-1a
- pegunigalsidase alfa
- pegvaliase
- pegvisomant
- probenecid
- ropeginterferon alfa-2b
- sulfinpyrazone
Krystexxa disease interactions
There are 2 disease interactions with Krystexxa (pegloticase) which include:
More about Krystexxa (pegloticase)
- Krystexxa consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (15)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antihyperuricemic agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.